About Anphar
Anphar is a Healthcare company based in Jammu (India). Development, production, and marketing of generic pharmaceuticals and active ingredients. The company has 47 employees. Its Indian entity Anphar Laboratories Private Limited reported revenue of ₹20.75 Cr. Anphar offers products and services including Generic Pharmaceuticals and Active Pharmaceutical Ingredients. Its focus areas include Pharmaceuticals, Generic Drugs, Development and Manufacturing and Chemicals.
Company details
Anphar is recognized as a global pharmaceutical company that specializes in the development, production, and marketing of generic and proprietary branded pharmaceuticals, along with active pharmaceutical ingredients. It was incorporated on January 15, 1987, with a focus on delivering quality materials at competitive prices. Quality is maintained as the primary priority, ensuring all products meet high standards for safety and efficacy. Commitments to dignity, equity in relationships, customer satisfaction, and environmental responsibility are upheld, while opportunities for employee development are provided. Overall, Anphars operations emphasize good health and well-being through reliable products and business conduct.
- Headquarters Jammu, India
- Employees 47
- SectorsHealthcare
- Email••••••••
- Legal Name Anphar Laboratories Pvt. Limited
- Date of Incorporation 15 Jan, 1987
- Jurisdiction Jammu, Jammu and Kashmir, India
- Annual Revenue₹20.75 Cr
FY 2025 · +27% YoY
- Net Profit₹2.10 Cr
FY 2025 · 10% margin
- EBITDA₹5.13 Cr
FY 2025 · 25% margin
- Employee Count47
Associated legal entities of Anphar
Anphar operates through Anphar Laboratories Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Anphar Laboratories Private Limited CIN U33112JK1987PTC000930 | Active | 15 Jan 1987 | Jammu, Jammu and Kashmir | ₹20.7 Cr | 47 | 3 | View details |
Products & Services of Anphar
Anphar offers a comprehensive portfolio of products and services, including Generic Pharmaceuticals and Active Pharmaceutical Ingredients.
The development, production, and marketing of generic drugs are carried out by Anphar to support the pharmaceutical industry.
Active pharmaceutical ingredients are produced and supplied by Anphar for use in various pharmaceutical applications.
Board of directors of Anphar Laboratories Private Limited (Anphar)
Anphar Laboratories Private Limited is the primary company behind Anphar. The board of Anphar Laboratories Private Limited currently have 3 directors; the longest-serving is Anil Gupta, appointed in 1987. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Anil Gupta DIN 00897796 | Director | 15 Jan 1987 | 39 yrs 9 mo | Anphar Laboratories Private Limited |
| Ankit Gupta DIN 06782180 | Director | 01 Jan 2014 | 12 yrs 9 mo | Anphar Laboratories Private Limited |
| Sukriti Sharma DIN 09682528 | Director | 22 Jul 2022 | 4 yrs 3 mo | Anphar Laboratories Private Limited |
Financials of Anphar
Figures of Anphar Laboratories Private Limited, the primary company behind Anphar, for FY 2025. Revenue was ₹20.75 Cr (+27% year on year). Net profit was ₹2.10 Cr (10% margin). EBITDA was ₹5.13 Cr (25% margin). Revenue has grown at a compounded annual rate of +2% over three years and 0% over five years.
- ₹20.75 CrRevenue · FY 2025 · +27% YoY
- ₹2.10 CrNet profit · 10% margin
- ₹5.13 CrEBITDA · 25% margin
- ₹1.19 CrPaid-up capital
- 47Employees (provident fund records)
- +2%Revenue CAGR, 3 years
- 0%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Anphar Laboratories Private Limited are on its company page.
Detailed financial statements for Anphar
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Anphar
Anphar is headquartered in Jammu, India. It is registered at Jammu, Jammu And Kashmir, India.
Anphar has 47 employees.
The primary company behind Anphar, Anphar Laboratories Private Limited, reported revenue of ₹20.75 Cr for FY 2025, up 27% year on year.
Anphar is recognized as a global pharmaceutical company that specializes in the development, production, and marketing of generic and proprietary branded pharmaceuticals, along with active pharmaceutical ingredients. It was incorporated on January 15, 1987, with a focus on delivering quality materials at competitive prices. Quality is maintained as the primary priority, ensuring all products meet high standards for safety and efficacy. Commitments to dignity, equity in relationships, customer satisfaction, and environmental responsibility are upheld, while opportunities for employee development are provided. Overall, Anphars operations emphasize good health and well-being through reliable products and business conduct.
Anphar offers Generic Pharmaceuticals and Active Pharmaceutical Ingredients.
Anphar operates through Anphar Laboratories Private Limited.
The legal entities of Anphar currently have 3 directors, including Sukriti Sharma, Anil Gupta, Ankit Gupta.